AdvaMed Comments to DOJ Anticompetitive Regulations RFC
AdvaMed Responds to DOJ’s Anticompetitive Regulations Inquiry
In response to the Department of Justice’s Anticompetitive Regulations Task Force Request for Comments, AdvaMed outlines how outdated and overly burdensome regulations hinder innovation and access in the medtech industry. This public comment advocates for reform that supports small businesses, promotes entrepreneurship, and improves patient care—especially in underserved communities.
Related Reading
Blog / Value-Based Collaborations
Centering the Patient Voice in Medtech Innovation
May 12, 2025
AdvaMed President and CEO Scott Whitaker describes the importance of engaging patients in every stage of medtech innovation.
Blog / Code of Ethics / Value-Based Collaborations
Updates to AdvaMed® Code of Ethics Discussed on Recent Episode of Capital Forum
August 29, 2022
AdvaMed®’s Deputy General Counsel and Senior, VP of Legal, Pat Fogarty, joined Jack Kalavritinos, host of Capital Forum, and Jonathan Turner, Global Head of Compliance, Privacy and Governance, Zoll Medical, to discuss the recent revisions the AdvaMed® Code.
Resource / Legal / Value-Based Collaborations
AdvaMed® Best Practice Guidance on Value-Based Arrangements
May 10, 2022
These arrangements to advance value-based care are designed to increase shared accountability among shareholders for quality of, access to and/or the total cost of care.
Blog / Code of Ethics / Value-Based Collaborations
AdvaMed® Approves Updated Code of Ethics
March 24, 2022
The AdvaMed® Board of Directors has approved revisions to the AdvaMed® Code of Ethics on Interactions with Health Care Professionals in the U.S., effective June 1, 2022.
News / Code of Ethics / Value-Based Collaborations
AdvaMed® Continues to Lead the Way in Compliance and Ethics with Revised Code of Ethics
March 18, 2022
AdvaMed®, the world’s largest trade organization representing medical technology manufacturers, today announced that its board of directors has unanimously approved revisions to the AdvaMed® Code of Ethics on Interactions with Health Care Professionals.
Value-Based Collaborations
Value-Based Collaborations
The U.S. health care system is transitioning from a fee-for-service and fee-for-product (volume-based) model to value-based paradigm to deliver more coordinated, high-quality, affordable health care.
Legal / Physicians Payment Sunshine Act / Value-Based Collaborations
Legal
AdvaMed® advocates on a global basis for the highest ethical standards and works to facilitate a legal environment that fosters medical technology innovation and timely patient access to safe and effective medical technologies.
Blog / Legal / Physicians Payment Sunshine Act / Value-Based Collaborations
Just the Beginning: Anti-Kickback Statute Reforms to Advance Value-Based Care
December 17, 2020
Unequal access to medical technologies and, more broadly, health care services continues to persist – often disproportionately impacting the lives of racial and ethnic minorities.